Epocrates cost in 2026: Epocrates+ pricing, app cost, subscription price and the free tier

The short answer: Epocrates has a free tier, and the paid version, Epocrates+, lists at $179.99 per year or $24.99 per month as of September 2026. The free app covers drug monographs, a basic interaction check and a pill identifier; the paid tier adds deeper clinical content, disease information and additional tools. For a lot of clinicians the free version is genuinely enough, so the real question is not the price but whether you need what the paid tier adds.

Epocrates is one of the oldest and most widely used point-of-care drug references, and its pricing is refreshingly simple next to the enterprise references. This piece breaks down what each tier costs, what the money buys, and when it is worth paying versus staying on the free app or reaching for a different kind of tool.

How much does Epocrates cost?

There are two consumer tiers, plus separate arrangements for organizations.

• Epocrates (free). The free app has been the draw for decades: drug monographs, dosing, a multi-drug interaction check and a pill identifier, at no cost. For fast drug lookups on a phone, it does the core job.
• Epocrates+. The paid subscription lists at $179.99 per year or $24.99 per month as of September 2026. It layers deeper clinical and disease content, additional calculators and reference material on top of the free drug tools.
• Teams and enterprise. athenahealth, which owns Epocrates, sells organizational and enterprise arrangements separately, priced by agreement rather than published as a headline number.

Prices change, so confirm the current figure on the Epocrates site before you subscribe. The list rates above are a starting point, not a quote.

The terms people search for interchangeably all refer to the same product. The Epocrates app cost, the Epocrates subscription cost and the Epocrates+ price are one figure: $179.99 a year, or $24.99 a month if you pay monthly. Annual billing is the cheaper of the two by a wide margin, since twelve monthly payments come to just under $300.

What is the pricing structure for a group or multi-site practice?

athenahealth sells epocrates+ as a group subscription alongside the individual plan, and group pricing is tiered by the number of licenses rather than published as a single list rate. In practice that means a multi-site urgent care group, a residency program or a hospital service line is quoted rather than charged a headline price, and the per-clinician rate falls as the license count rises. Group enquiries go through athenahealth rather than the consumer checkout.

Because those tiers are quoted rather than published, treat any specific group figure you find on a software directory as unverified. We do not repeat aggregator pricing here for the same reason we do not repeat it for Micromedex: those numbers are frequently stale or simply wrong, and a budget built on one is a budget built on a guess. The reliable anchor for planning is the published individual rate of $179.99 per clinician per year, with the expectation that a negotiated group rate lands below it at volume. If you are running the procurement rather than buying a single seat, our guide to institutional and group license costs sets out what drives a quote across every major vendor and the questions that get comparable numbers back.

One practical note for anyone evaluating Epocrates from outside the country: as of September 2026 the epocrates site gates access to the United States and states that it is no longer supported outside the US. For a US practice that changes nothing, but it does mean international colleagues on a shared license will not be able to use it.

Is Epocrates+ worth it?

It depends on whether you use Epocrates as a drug reference or as a broader clinical reference. If your lookups are overwhelmingly "what is the dose, what does it interact with, what does this pill look like," the free app already covers that, and the upgrade buys you content you may rarely open. If you regularly want disease summaries, guideline content and the extra calculators in one place, Epocrates+ consolidates that for a modest annual fee, and $179.99 a year is inexpensive next to the enterprise references.

The honest test is your own usage. Look at what you actually reach Epocrates for over a week. If it is drug facts, the free tier is likely enough. If you keep wishing it went deeper on the clinical side, the paid tier is a fair deal. Either way, it is worth keeping your practice's software subscriptions tracked in one place so a $25-a-month tool that nobody opens does not quietly renew year after year.

How does Epocrates compare to UpToDate on price?

They sit in different price brackets because they do different jobs. Epocrates+ at $179.99 a year is a drug-and-clinical reference built for fast lookups. UpToDate buys a graded editorial reference written by named physician authors, and Wolters Kluwer publishes no individual price for it, quoting it only after a country and role selection. Epocrates is optimized for speed at the point of care; UpToDate sits well above it on price and is built for depth and defensible, graded recommendations. Neither is overpriced for what it is; they are aimed at different needs. If you are weighing the deeper reference, the full breakdown is in what UpToDate really costs, and the enterprise end of the market is covered in what Micromedex costs.

How does Epocrates compare to Lexicomp on price?

Epocrates is the cheaper of the two by roughly half. Lexicomp, now sold as UpToDate Lexidrug, has no free tier at all, and Apple's US App Store lists its personal subscription at $29.99 a month, which is about $360 across a year against $179.99 for Epocrates+. Institutional Lexidrug pricing is negotiated per organization and never published, so the app store figure is the only individual number either party makes visible.

The price gap is buying depth, not features. Lexidrug carries the monograph detail that hospital pharmacists verify orders against, and Epocrates is built to answer a dose or an interaction in the thirty seconds you have between rooms. For ambulatory clinicians paying personally, Epocrates usually wins on both cost and speed. For anyone whose orders get checked against a pharmacy standard, that is the wrong saving to make. We put the two side by side in Epocrates vs Lexicomp, and break the pricing down further in what Lexicomp costs.

Is Epocrates worth paying for when Medscape is free?

This is the sharper version of the value question, and it deserves a direct answer: on drug reference alone, no. Medscape is free with no in-app purchases at all, and its listing states prescribing information on more than 9,200 drugs against the 6,000-plus monographs Epocrates advertises in its free tier. It also throws in more than 450 medical calculators and free CME carrying ABIM MOC points. Judged on what you get without paying, Medscape covers more.

What that comparison misses is that the $179.99 was never buying drug data. Epocrates+ adds the disease reference, differential diagnosis support, lab value interpretation and the dosing calculators. If you want those, the upgrade is the product. If you want a drug lookup, you already have one for free, from either vendor.

The other thing the free Epocrates tier has that is worth knowing about is a ceiling: its interaction checker caps at 30 medications per check. Irrelevant most of the time, and precisely the wrong limit to hit on a long-term care resident, which is the population where interaction checking matters most. We compare the two apps in full in Epocrates vs Medscape, and cover what the free tool includes in what Medscape costs.

Is the free version of Epocrates good enough?

For drug lookups, often yes. The free app's monographs, dosing, interaction check and pill identifier cover the everyday questions most clinicians ask a drug reference, which is why the free tier has stayed so popular. Where it stops is depth: it is a reference to consult, not a decision-support layer that watches a specific prescription. It checks the interaction when you ask it to; it does not take a full medication list and surface the interaction, the contraindication and the renal dose adjustment together, unprompted, at the moment you prescribe.

What a drug reference does not do at the point of prescribing

This is the limitation shared by every reference, free or paid, Epocrates or UpToDate: it waits to be asked. To catch a problem with the prescription in front of you, you have to remember to run the interaction check, then the contraindication check, then think about the renal dose, then consider whether a safer alternative exists. Four questions, several lookups, on a schedule that is already behind. The errors that slip through are the checks nobody thought to run.

Prescriber.io is built for that moment rather than the lookup. You enter the drug or scenario once and it checks interactions, flags contraindications and allergy conflicts, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, together in one card with the sources cited on each flag. Clinicians who want that shape rather than a reference app usually land on our Epocrates alternative page. It is decision-support for licensed clinicians, not autonomous prescribing: you review each flag, verify against official sources, and sign. You can try the check at the top of this page, and Epocrates stays perfectly useful next to it for a quick, free drug lookup.

Are there Epocrates discounts or a free trial?

The most important discount is the free tier itself, which is permanent rather than a trial and covers the core drug tools. For Epocrates+, athenahealth periodically runs promotional pricing and trial windows, and students and residents should look for trainee terms before paying the standard rate, the same way you would with any clinical subscription. Institutional and group arrangements are negotiated separately, so if your practice or hospital licenses Epocrates, you may already have paid access without a personal subscription.

Two habits save clinicians money here. First, check whether your employer, residency program or medical library already provides the paid tier before you subscribe personally. Second, review your own usage once a year: a $24.99 monthly plan that renews on autopilot while you only ever open the free features is a quiet, avoidable cost.

Free versus paid: how to decide in one pass

You can settle this quickly. If, over a typical week, you reach for Epocrates almost entirely to answer drug questions, doses, interactions, pill identification, the free app already does that, and Epocrates+ is optional. If you keep hitting the ceiling and wishing it went deeper into disease content, guidelines and calculators, the paid tier consolidates that for a low annual fee and is a reasonable buy. There is no wrong answer, only a fit to how you actually work, and $179.99 a year is small enough that the decision rarely hinges on the price alone.

The bottom line

Epocrates is free at its core, with Epocrates+ at $179.99 a year or $24.99 a month adding deeper clinical content, re-verified against the vendor app store listing in September 2026. For most drug lookups the free tier is enough; upgrade only if you genuinely use the broader reference material. And remember that any drug reference answers the question you ask, while the prescribing moment usually asks several at once.